AI assistant
Merck & Co., Inc. — Director's Dealing 2019
Jan 10, 2019
284_dirs_2019-01-10_eaeb2064-6ecb-4a42-baf5-451f6ac3e116.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-01-01
Reporting Person: Clyburn Frank (EVP, Chief Commercial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 61724.9410 | Direct |
| Common Stock - 401(k) Plan | 1395.4461 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock | $ | Common Stock (2059.8360) | Direct | ||
| Restricted Stock Unit | $ | 2021-05-04 | Common Stock (5714.0000) | Direct | |
| Restricted Stock Unit | $ | 2020-05-05 | Common Stock (3752.0000) | Direct | |
| Restricted Stock Unit | $ | 2019-05-10 | Common Stock (4389.0000) | Direct | |
| Restricted Stock Unit | $ | 2021-10-30 | Common Stock (6862.0000) | Direct | |
| Stock Option (right to buy) | $39.2900 | 2022-05-01 | Common Stock (43876.0000) | Direct | |
| Stock Option (right to buy) | $44.9800 | 2023-05-05 | Common Stock (38647.0000) | Direct | |
| Stock Option (right to buy) | $54.6800 | 2026-05-09 | Common Stock (54329.0000) | Direct | |
| Stock Option (right to buy) | $57.7500 | 2028-05-03 | Common Stock (40255.0000) | Direct | |
| Stock Option (right to buy) | $58.2200 | 2024-05-01 | Common Stock (38514.0000) | Direct | |
| Stock Option (right to buy) | $58.3300 | 2025-02-08 | Common Stock (5500.0000) | Direct | |
| Stock Option (right to buy) | $59.8600 | 2025-04-30 | Common Stock (43344.0000) | Direct | |
| Stock Option (right to buy) | $63.9700 | 2027-05-04 | Common Stock (34237.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
F3: The Merck & Co., Inc. Deferral Program includes the right of redesignation to other investement measures within the Program.
F4: Distributions of phantom stock are made in shares of Common Stock of Merck & Co., Inc., with cash payable for partial shares, in accordance with a distribution schedule elected by the reporting person. This distribution is subject to conditions and limitations of the Merck & Co., Inc. Deferral Program.
F5: 1-for-1
F6: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F7: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F8: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
F9: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.
F10: The option became exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016.
F11: The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
F12: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F13: The option became exercisable in equal installments on 5/2/2015, 5/2/2016 and 5/2/2017.
F14: The option became exercisable in equal installments on 2/9/2016, 2/9/2017 and 2/9/2018.
F15: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
F16: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.